An Elevation of Serum Ferritin Level Might Increase Clinical Risk for the Persistence of Patent Ductus Arteriosus, Sepsis and Bronchopulmonary Dysplasia in Erythropoietin-Treated Very-Low-Birth-Weight Infants

Publisher： Karger

E-ISSN： 1661-7819|111|1|68-75

ISSN： 1661-7800

Source： Neonatology, Vol.111, Iss.1, 2016-08, pp. : 68-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet Counts in the First Seven Days of Life and Patent Ductus Arteriosus in Preterm Very Low-Birth-Weight Infants

By  

Neonatology, Vol. 106, Iss. 3, 2014-07 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Continuous Infusion of Ibuprofen for Treatment of Patent Ductus Arteriosus in Very Low Birth Weight Infants

By  

Neonatology, Vol. 105, Iss. 1, 2013-11 ,pp. : 46-54

Karger

Access to resources Recommend Favorite

Evidence-Based Neonatal Drug Therapy for Prevention of Bronchopulmonary Dysplasia in Very-Low-Birth-Weight Infants

By  

Neonatology, Vol. 93, Iss. 4, 2008-06 ,pp. : 284-287

Karger

Access to resources Recommend Favorite

WEIGHT LOSS AND BRONCHOPULMONARY DYSPLASIA IN VERY LOW BIRTH WEIGHT INFANTS

By Maayan-Metzger Ayala   Mazkereth Ram   Kuint Jacob  

Fetal and Pediatric Pathology, Vol. 27, Iss. 4-5, 2008-12 ,pp. : 215-222

Informa Healthcare

Access to resources Recommend Favorite

Very Low Birth Weight Monochorionic Diamniotic Twins as a Risk Factor for Symptomatic Patent Ductus Arteriosus

By  

Neonatology, Vol. 109, Iss. 3, 2016-02 ,pp. : 228-234

Karger

Access to resources Recommend Favorite